Discrepancies in the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.

[1]  J. Ahlskog,et al.  Myelopathy due to copper deficiency following gastrointestinal surgery. , 2003, Archives of neurology.

[2]  J. Gross,et al.  Myelopathy due to copper deficiency , 2003, Neurology.

[3]  N. Barbaro,et al.  Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. , 2003, Archives of neurology.

[4]  A. Aksamit.  Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt-Jakob disease, laboratory standards, and quantitation. , 2003, Archives of neurology.

[5]  N. R. Holland,et al.  CNS demyelination associated with copper deficiency and hyperzincemia , 2002, Neurology.

[6]  H. Stuerenburg,et al.  Copper deficiency-associated myelopathy in a 45-year-old woman , 2001, Journal of Neurology.

[7]  J. Yagüe,et al.  The impact of the introduction of the 14-3-3 protein assay in the surveillance of sporadic Creutzfeldt-Jakob disease in Catalonia , 2001, Journal of Neurology.

[8]  H. Budka,et al.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease , 2000, Neurology.

[9]  B. Steinhoff,et al.  Current clinical diagnosis in Creutzfeldt‐Jakob disease: Identification of uncommon variants , 2000, Annals of neurology.

[10]  E. Tolosa,et al.  Detection of 14‐3‐3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders , 1999, Annals of neurology.

[11]  P. Castaigne,et al.  Creutzfeldt‐Jakob disease: Clinical analysis of a consecutive series of 230 neuropathologically verified cases , 1986, Annals of neurology.

[12]  S. Jc,et al.  Characterization of zinc-binding proteins of plasma in familial hyperzincemia. , 1982 .

[13]  A. Prasad,et al.  Hypocupremia induced by zinc therapy in adults. , 1978, JAMA.

[14]  J. C. Smith,et al.  Elevated plasmz zinc: a heritable anomaly. , 1976, Science.